Massachusetts S1366 aims to enhance newborn screening tests by adding specific Lysosomal Storage Disorders.
Massachusetts S1366 seeks to improve newborn screening tests by adding screening for Krabbe, Fabry, Gaucher, Pompe, MPS I, and Niemann Pick A/B diseases. This bill amends Section 110A of chapter 111 of the General Laws to include these additional disorders in the mandatory screening process. The goal is to ensure early detection and treatment of these conditions, which can significantly impact a child's health.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.